DIATRIZOATE MEGLUMINE — all Canadian products
23 DINs
1 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is DIATRIZOATE MEGLUMINE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02228564 | GASTROGRAFIN | BRACCO IMAGING CANADA | Solution | Oral; Rectal | DIATRIZOATE MEGLUMINE 66 %; DIATRIZOATE SODIUM 10 % | Marketed | |
| 01995669 | GASTROGRAFIN LIQ | SQUIBB DIAGNOSTICS, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Liquid | Refer (See Dosage Form); Oral | DIATRIZOATE MEGLUMINE 66 %; DIATRIZOATE SODIUM 10 % | Cancelled Post Market | |
| 02180634 | HYPAQUE-M 18% | AMERSHAM HEALTH INC | Solution | Intravenous; Cystography | DIATRIZOATE MEGLUMINE 18 % | Cancelled Post Market | |
| 02026945 | HYPAQUE-M 18% LIQ | SANOFI CANADA, INC. | Liquid | Intravenous; Cystography | DIATRIZOATE MEGLUMINE 18 % | Cancelled Post Market | |
| 02180642 | HYPAQUE-M 30% | AMERSHAM HEALTH INC | Solution | Intravenous; Cystography | DIATRIZOATE MEGLUMINE 30 % | Cancelled Post Market | |
| 02026910 | HYPAQUE-M 30% LIQ | SANOFI CANADA, INC. | Liquid | Intravenous; Cystography | DIATRIZOATE MEGLUMINE 30 % | Cancelled Post Market | |
| 02180669 | HYPAQUE-M 60% | AMERSHAM HEALTH INC | Solution | Arthography; Intravenous; Cystography | DIATRIZOATE MEGLUMINE 60 % | Cancelled Post Market | |
| 02026929 | HYPAQUE-M 60% LIQ | SANOFI CANADA, INC. | Liquid | Cystography; Intravenous; Arthography | DIATRIZOATE MEGLUMINE 60 % | Cancelled Post Market | |
| 02026996 | HYPAQUE-M 76% LIQ | SANOFI CANADA, INC. | Liquid | Intravenous; Intra-Arterial | DIATRIZOATE MEGLUMINE 66 %; DIATRIZOATE SODIUM 10 % | Cancelled Post Market | |
| 01904841 | HYPAQUE-M LIQ 76% USP | STERLING WINTHROP INC. | Liquid | Intravenous | DIATRIZOATE MEGLUMINE 66 %; DIATRIZOATE SODIUM 10 % | Cancelled Post Market | |
| 00571024 | MD-60 | TYCO HEALTHCARE | Solution | Intravenous; Intra-Arterial | DIATRIZOATE MEGLUMINE 520 MG; DIATRIZOATE SODIUM 80 MG | Cancelled Post Market | |
| 00569739 | MD-76 | TYCO HEALTHCARE | Solution | Intra-Arterial; Intravenous | DIATRIZOATE MEGLUMINE 660 MG; DIATRIZOATE SODIUM 100 MG | Cancelled Post Market | |
| 02237155 | RENO-60 | BRACCO IMAGING CANADA | Liquid | Intravenous | DIATRIZOATE MEGLUMINE 600 MG | Cancelled Post Market | |
| 02228572 | RENO-DIP | BRACCO IMAGING CANADA | Liquid | Intravenous | DIATRIZOATE MEGLUMINE 30 % | Cancelled Post Market | |
| 00353841 | RENO-M-60 | SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Liquid | Intramuscular; Intravenous | DIATRIZOATE MEGLUMINE 600 MG | Cancelled Post Market | |
| 01973991 | RENO-M-DIP LIQ 30% | SQUIBB DIAGNOSTICS, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Liquid | Intravenous | DIATRIZOATE MEGLUMINE 30 % | Cancelled Post Market | |
| 02232998 | RENOCAL-76 | BRACCO IMAGING CANADA | Liquid | Intravenous | DIATRIZOATE MEGLUMINE 66 %; DIATRIZOATE SODIUM 10 % | Cancelled Post Market | |
| 02228580 | RENOGRAFIN-60 - LIQ IV | BRACCO IMAGING CANADA | Liquid | Intravenous | DIATRIZOATE MEGLUMINE 52 %; DIATRIZOATE SODIUM 8 % | Cancelled Post Market | |
| 01974009 | RENOGRAFIN-60 LIQ | SQUIBB DIAGNOSTICS, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Liquid | Intravenous | DIATRIZOATE MEGLUMINE 52 %; DIATRIZOATE SODIUM 8 % | Cancelled Post Market | |
| 02228637 | RENOGRAFIN-76 - LIQ IV | BRACCO IMAGING CANADA | Liquid | Intravenous | DIATRIZOATE MEGLUMINE 66 %; DIATRIZOATE SODIUM 10 % | Cancelled Post Market | |
| 01963929 | RENOGRAFIN-76 LIQ | SQUIBB DIAGNOSTICS, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Liquid | Intravenous | DIATRIZOATE MEGLUMINE 66 %; DIATRIZOATE SODIUM 10 % | Cancelled Post Market | |
| 00184330 | SINOGRAFIN | SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Liquid | Intrauterine | DIATRIZOATE MEGLUMINE 52.7 %; MEGLUMINE IODIPAMIDE 26.9 % | Cancelled Post Market | |
| 02228599 | SINOGRAFIN - LIQ IU | BRACCO IMAGING CANADA | Liquid | Intrauterine | DIATRIZOATE MEGLUMINE 52.7 %; MEGLUMINE IODIPAMIDE 26.9 % | Cancelled Post Market |
Browse other molecules: